Table 7 Reasons why POs where in favour of screening
Rank | Shorter time to diagnostic | Early access to treatments | Inclusion in clinical trials | Preventive care | Genetic counselling |
|---|---|---|---|---|---|
1 | 13 (50%) | 18 (69%) | 8 (33%) | 11 (44%) | 13 (48%) |
2 | 7 (27%) | 5 (19%) | 6 (25%) | 9 (36%) | 7 (26%) |
3 | 3 (12%) | 1 (4%) | 4 (17%) | 3 (12%) | 4 (15%) |
4 | 2 (8%) | 2 (8%) | 0 | 2 (8%) | 2 (7%) |
5 | 1 (4%) | 0 | 5 (21%) | 0 | 1 (4%) |
6 | 0 | 0 | 1 (4%) | 0 | 0 |